Patients with Chronic Lymphocyte Leukemia (CLL) Have Naturally Occurring Antibodies Against the Receptor Tyrosine Kinase (ROR1)

被引：0
|
作者：
Hojjat-Farsangi, Mohammad [1 ]
Mozaffari, Fariba [1 ]
Daneshmanesh, Amir Hossein [1 ]
Osterborg, Anders [2 ]
Shokri, Faze [3 ]
Mellstedt, Hakan [4 ]
机构：
[1] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, Stockholm, Sweden
[2] Karolinska Univ Hosp, Dept Hematol, Stockholm, Sweden
[3] Univ Tehran Med Sci, Dept Immunol, Sch Publ Hlth, Tehran, Iran
[4] Karolinska Inst, Karolinska Univ Hosp, Dept Oncol Radiumhemmet & Hematol, Canc Ctr Karolinska, Stockholm, Sweden
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：773 / 773
页数：1
相关论文
共 50 条
  • [41] Receptor Tyrosine Kinase Screening in Ischemic Heart Identifies ROR1 as a Potential Target for the Treatment of Ischemia
    Heliste, Juho
    Paatero, Ilkka
    Jokilammi, Anne
    Chakroborty, Deepankar
    Stark, Christoffer
    Savunen, Timo
    Elenius, Klaus
    CIRCULATION, 2017, 136
  • [42] Cytoskeleton Network and Cellular Migration Modulated by Nuclear-localized Receptor Tyrosine Kinase ROR1
    Tseng, Hsiao-Chun
    Kao, Hsiao-Wei
    Ho, Meng-Ru
    Chen, Yet-Ran
    Lin, Tin-Wei
    Lyu, Ping-Chiang
    Lin, Wen-Chang
    ANTICANCER RESEARCH, 2011, 31 (12) : 4239 - 4249
  • [43] Signal Transducer and Activator of Transcription (Stat)-3 Activates the Receptor Tyrosine Kinase-Like Orphan (ROR)-1 Gene in Chronic Lymphocytic Leukemia (CLL)
    Li, Ping
    Harris, David
    Liu, Zhiming
    Keating, Michael
    Estrov, Zeev
    BLOOD, 2009, 114 (22) : 29 - 29
  • [44] HIGH LEVEL OF COBLL1, A NOVEL ROR1 BINDING PARTNER, IDENTIFIES CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS WITH MUTATED IGHV
    Plesingerova, H.
    Janovska, P.
    Shaik, A.
    Poppova, L.
    Libra, A.
    Plevova, K.
    Machac, J.
    Slapak, I.
    Pavlova, S.
    Pospisilova, S.
    Bryja, V.
    HAEMATOLOGICA, 2014, 99 : 39 - 39
  • [45] First-in-Class Oral Small Molecule Against the Tyrosine Kinase ROR1 (KAN0439834) Induced Significant Apoptosis of Chronic Lymphocytic Leukemia Cells
    Hojjat-Farsangi, Mohammad
    Daneshmanesh, Amir Hossein
    Mozaffari, Fariba
    Hansson, Lotta
    Vagberg, Jan
    Bystrom, Styrbjorn
    Olsson, Elisabeth
    Lofberg, Charlotta
    Norstrom, Charlotta Carina
    Schultz, Johan
    Norin, Martin
    Olin, Thomas
    Osterborg, Anders
    Moshfegh, Ali
    Mellstedt, Hakan
    BLOOD, 2017, 130
  • [46] Receptor tyrosine kinase-like orphan receptor 1 (ROR-1): An emerging target for diagnosis and therapy of chronic lymphocytic leukemia
    Aghebati-Maleki, Leili
    Shabani, Mahdi
    Baradaran, Behzad
    Motallebnezhad, Morteza
    Majidi, Jafar
    Yousefi, Mehdi
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 88 : 814 - 822
  • [47] Overexpression of orphan receptor tyrosine kinase Ror1 as a putative tumor-associated antigen in Iranian patients with acute lymphoblastic leukemia (vol 28, pg 318, 2007)
    Omran, Hossein Asgarian
    TUMOR BIOLOGY, 2008, 29 (02) : 136 - 136
  • [48] Exploration of macrocyclic peptide binders to the extracellular CRD domain of human receptor tyrosine kinase-like orphan receptor 1 (ROR1)
    Qiao, Jennifer X.
    Witmer, Mark R.
    Lee, Ving
    Wang, Tammy C.
    Reid, Patrick C.
    Arioka, Yuki
    Farr, Glen
    Hill-Drzewi, Melissa
    Schweizer, Liang
    Yamniuk, Aaron
    Cheng, Lin
    Abramczyk, Bozena
    Corbett, Martin
    Calambur, Deepa
    Szapiel, Nicolas
    Ryseck, Rolf
    Ponath, Paul
    Poss, Michael A.
    Carter, Percy
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 98
  • [49] Development of Cirmtuzumab Antibody-Drug Conjugates (ADCs) Targeting Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1)
    Mian, Yousaf A.
    Widhopf, George F., II
    Thanh-Trang Vo
    Jessen, Katti
    Rassenti, Laura Z.
    Kipps, Thomas J.
    BLOOD, 2018, 132
  • [50] Human neural tissues express a truncated Ror1 receptor tyrosine kinase, lacking both extracellular and transmembrane domains
    Reddy, UR
    Phatak, S
    Pleasure, D
    ONCOGENE, 1996, 13 (07) : 1555 - 1559
12345